04/08/2024
6:09 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:02 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:58 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:30 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
6:35 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:37 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
6:10 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:22 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
6:09 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
3:05 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
6:14 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:09 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
8:35 PM | Eansor Norman David (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:32 PM | ELMS STEVE (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:33 PM | Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Wilson John Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:34 PM | Knobil Katharine (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
5:44 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
